Medican Enterprises, Inc. is a bio-pharmaceutical company. The Company is engaged in wholesale medical marijuana production, cultivation, and wholesale distribution of cannabis related products. Through joint ventures with development partners all over Canada and the United States, the Company builds and operates medical marijuana cultivation and research centers. The Company focuses on cultivating approximately five strains of cannabis, including High tetrahydrocannabinol (THC)/Low Cannabidiol (CBD), Medium THC/Low CBD, Medium THC/Medium CBD and Low TCH/High CBD. The Company provides strategic planning, valuation, project debt and corporate finance solutions to its joint venture partners in order to capitalize on the growing medical marijuana market and fund multiple facilities. The Company's subsidiary, Medican Systems Inc., is a licensed producer of medical marijuana under the new program marijuana for medical purposes regulation.